Serum tumor markers patient allocation good-risk poor-risk clinical trials patients germ cell tumors allocation patients advanced germ cell tumors GCT different treatment programs clinical characteristics standard design clinical trials today Studies substantial differences entry criteria differences outcome clinical trials factors differences clear due patient selection biases unselected consecutive patients good-risk poor-risk treatment programs Memorial Sloan-Kettering Cancer Center MSKCC risk status Indiana University IU Classification results Southeastern Cancer Study Group SECSG results criteria substantial agreement total end results identification good-risk patients results poor-risk patients patients poor-risk MSKCC criteria Indiana criteria major discrepancy IU Stage patients complete response major factor difference risk assignment use serum tumor markers Serum tumor markers risk assignment criteria GCT clinical trials number good-risk GCT patients poor-risk trials 